Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes

Jennifer A Namazy1, Vanessa E Murphy, Heather Powell

  • 1Dept of Allergy–Immunology, Scripps Clinic, San Diego, CA 92108, USA. janamazy@mac.com

Insights

Maternal asthma exacerbations and corticosteroid use increase risks for low birth weight and preterm delivery. Moderate-to-severe asthma during pregnancy is linked to small for gestational age and low birth weight infants.

Area of Science:

  • Obstetrics and Gynecology
  • Pulmonology
  • Neonatology

Background:

  • Asthma is a common chronic respiratory condition affecting women of reproductive age.
  • Poorly controlled asthma during pregnancy can lead to adverse maternal and fetal outcomes.
  • The specific impact of asthma exacerbations, corticosteroid use, and severity on perinatal outcomes requires further clarification.

Purpose of the Study:

  • To systematically review and meta-analyze the association between maternal asthma exacerbations, oral corticosteroid use, asthma severity, and prematurity and intrauterine growth restriction.
  • To quantify the risks of specific perinatal outcomes in relation to maternal asthma control.

Main Methods:

  • Systematic review and meta-analysis of cohort studies published between 1975 and March 2012.
  • Inclusion of nine studies reporting perinatal outcomes (low birth weight, preterm birth, small for gestational age) stratified by maternal asthma status.
  • Statistical analysis using relative risks (RR) and 95% confidence intervals (CI).

Main Results:

  • Maternal asthma exacerbations were significantly associated with low birth weight (RR 3.02) and preterm delivery (RR 1.54).
  • Oral corticosteroid use in asthmatic mothers was linked to low birth weight (RR 1.41) and preterm delivery (RR 1.51).
  • Moderate-to-severe maternal asthma increased the risk of small for gestational age (RR 1.24) and low birth weight (RR 1.15) infants.

Conclusions:

  • Asthma exacerbations, oral corticosteroid use, and moderate-to-severe asthma during pregnancy are associated with adverse perinatal outcomes.
  • These outcomes include preterm delivery, low birth weight, and small for gestational age infants.
  • Further research is needed to understand the effect of maternal asthma control on perinatal health.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...